Jeffrey P. George
Director · LENZ Therapeutics, Inc.
- 2026
- Jun 16, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey P. George files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- John Kiely - $882K in AMRX purchases and sales in the last 12 months
- Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
- Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
- Shawn Olsson - $261K in LENZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey P. George?
Jeffrey P. George is a corporate insider, tracked as Director of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey P. George last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 3 filings going back to 2026.
Has Jeffrey P. George been buying or selling stock?
Recorded transactions: 1 open-market purchase ($50K) and 0 open-market sales across all tracked filings.
